Movement Alert｜Liquidia Technologies Inc Rises 5.41% in Regular Trading, Trading at $88.475

Market Focus

Aug 05

On August 5, Liquidia Technologies Inc rose 5.41% in regular trading, trading at $88.475 USD/share, with Turnover of $35.17 million.

Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector showed mixed performance. Among individual stocks, Eli Lilly up 0.41%, Pfizer up 2.14%, AstraZeneca PLC down 0.1%, Johnson & Johnson down 0.73%, Merck up 1.0%.

Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs, with current emphasis on pulmonary arterial hypertension treatment. Its lead product YUTREPIA generated approximately $130 million in net product sales in Q1, with EPS of $0.52. The company is scheduled to report next quarterly results on August 12, with market consensus EPS estimate of $0.70.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1118013372"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1118013372\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1118013372?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 00:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118013372","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Liquidia Technologies Inc Rises 5.41% in Regular Trading, Trading at $88.475","media":"Market Focus","content":"<p><p>On August 5, Liquidia Technologies Inc rose 5.41% in regular trading, trading at $88.475 USD/share, with Turnover of $35.17 million.</p><p>Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector showed mixed performance. Among individual stocks, Eli Lilly up 0.41%, Pfizer up 2.14%, AstraZeneca PLC down 0.1%, Johnson & Johnson down 0.73%, Merck up 1.0%.</p><p>Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs, with current emphasis on pulmonary arterial hypertension treatment. Its lead product YUTREPIA generated approximately $130 million in net product sales in Q1, with EPS of $0.52. The company is scheduled to report next quarterly results on August 12, with market consensus EPS estimate of $0.70.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Liquidia Technologies Inc Rises 5.41% in Regular Trading, Trading at $88.475</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Liquidia Technologies Inc Rises 5.41% in Regular Trading, Trading at $88.475\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-05 00:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 5, Liquidia Technologies Inc rose 5.41% in regular trading, trading at $88.475 USD/share, with Turnover of $35.17 million.</p><p>Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector showed mixed performance. Among individual stocks, Eli Lilly up 0.41%, Pfizer up 2.14%, AstraZeneca PLC down 0.1%, Johnson & Johnson down 0.73%, Merck up 1.0%.</p><p>Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs, with current emphasis on pulmonary arterial hypertension treatment. Its lead product YUTREPIA generated approximately $130 million in net product sales in Q1, with EPS of $0.52. The company is scheduled to report next quarterly results on August 12, with market consensus EPS estimate of $0.70.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LQDA","symbol_name":"Liquidia Technologies Inc","start_time":0,"source_url":"","article_id":"1118013372","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118013372","pubTimestamp":1785860326,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 5, Liquidia Technologies Inc rose 5.41% in regular trading, trading at $88.475 USD/share, with Turnover of $35.17 million.Within the Pharmacy sector where Liquidia Technologies Inc belongs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LQDA":"Liquidia Technologies Inc"},"translate_title":"走势警报|Liquidia Technologies Inc 在常规交易中上涨 5.41%，交易价格为 88.475 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LQDA":1},"content_text":"On August 5, Liquidia Technologies Inc rose 5.41% in regular trading, trading at $88.475 USD/share, with Turnover of $35.17 million.Within the Pharmacy sector where Liquidia Technologies Inc belongs, the overall sector showed mixed performance. Among individual stocks, Eli Lilly up 0.41%, Pfizer up 2.14%, AstraZeneca PLC down 0.1%, Johnson & Johnson down 0.73%, Merck up 1.0%.Liquidia Corporation is a biopharmaceutical company focused on developing, manufacturing, and commercializing products for unmet patient needs, with current emphasis on pulmonary arterial hypertension treatment. Its lead product YUTREPIA generated approximately $130 million in net product sales in Q1, with EPS of $0.52. The company is scheduled to report next quarterly results on August 12, with market consensus EPS estimate of $0.70.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}